Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Opens counter-regulatory axis to RAAS; extends sodium homeostasis models and leaves open peptide-based therapies.
Flier et al. (1985) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: